• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement source.

作者信息

Ploug M, Jessen T E, Welinder K G, Barkholt V

出版信息

Anal Biochem. 1985 May 1;146(2):411-7. doi: 10.1016/0003-2697(85)90560-3.

DOI:10.1016/0003-2697(85)90560-3
PMID:3927773
Abstract

A hemolytic plate assay specific for active human complement component C3 is described. The method is well suited for tracing active C3 during preparative purification or for screening of plasma samples. The assay is based on activation of the alternative pathway of complement by unmodified rabbit erythrocytes. Plasma treated with methylamine supplies the essential complement components other than C3. The lytic reaction is complete in 5 h at 37 degrees C and is unchanged by incubation overnight. The dose-response curve, i.e., lysis diameter versus logarithm of C3 concentration, is linear within 0.1-10 times normal plasma concentrations of C3. The standard deviation is below 10%. The hemolytic agarose plates are easy and inexpensive to prepare, and they can be stored at 4 degrees C for 2 weeks before use. This paper describes the optimal conditions of the assay and proves its specificity. Its use in C3 preparation and plasma screening for C3 is discussed.

摘要

相似文献

1
Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement source.
Anal Biochem. 1985 May 1;146(2):411-7. doi: 10.1016/0003-2697(85)90560-3.
2
A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.一种使用甲胺处理的血浆进行人补体成分C3溶血测定的简单替代途径。
J Immunol Methods. 1983 May 27;60(1-2):89-100. doi: 10.1016/0022-1759(83)90338-1.
3
A simple hemolytic assay for bovine complement component C3.
Vet Immunol Immunopathol. 1987 Jun;15(3):239-51. doi: 10.1016/0165-2427(87)90086-9.
4
C3-like activity in C3-deficient dog serum.
Complement. 1987;4(1):53-60. doi: 10.1159/000463007.
5
Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.非共价结合的C3通过替代途径增强兔红细胞的裂解。
Immunology. 1985 Dec;56(4):735-41.
6
Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant.原发性大鼠乳腺癌的血浆疗法:用琼脂糖衍生物吸收血浆过程中C3消耗对抗凝剂的依赖性。
Cancer Res. 1985 Sep;45(9):4122-7.
7
Determination of optimal in vitro conditions for caprine alternative complement pathway assay.
Vet Immunol Immunopathol. 1992 May;32(3-4):359-64. doi: 10.1016/0165-2427(92)90057-w.
8
Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.一种用于定量检测人血清中替代补体途径激活的酶联免疫吸附测定法的开发与应用。
J Clin Invest. 1984 Jan;73(1):160-70. doi: 10.1172/JCI111187.
9
Simple method to distinguish between primary and secondary C3 deficiencies.区分原发性和继发性C3缺乏症的简单方法。
Clin Diagn Lab Immunol. 2003 Mar;10(2):216-20. doi: 10.1128/cdli.10.2.216-220.2003.
10
Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.原发性大鼠乳腺癌的血清疗法:乙二胺四乙酸具有抑制作用,而[亚乙基双(氧乙烯基腈)]四乙酸则无抑制作用。
Cancer Res. 1986 Aug;46(8):3886-90.

引用本文的文献

1
Maternal transfer and protective role of the alternative complement components in zebrafish Danio rerio.斑马鱼(Danio rerio)中替代补体成分的母体传递及保护作用
PLoS One. 2009;4(2):e4498. doi: 10.1371/journal.pone.0004498. Epub 2009 Feb 18.